MedWatch

William Demant Invest increased its investment portfolio by USD 3.4bn in 2021

Investment firm William Demant Invest had a splendid 2021, noting advancement for several of its portfolio companies, including not least hearing aid manufacturer Demant.

Niels Jacobsen, CEO at William Demant Invest (WDI) | Photo: Lars Krabbe/Ritzau Scanpix

Affluent investment firm William Demant Invest exited 2021 with an excellent annual report, adding a sum of DKK 23bn (USD 3.4bn) to its investment portfolio.

”I am very pleased with the performance of the companies and especially their ability to take part in, and even drive, the upturn after the corona crisis. I see this as a sign of solid and healthy operations and leadership in the companies,” says CEO at William Demant Invest (WDI) Niels Jacobsen in the report.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs